SCHEMBL6950135

SCHEMBL6950135

CCOC(=O)C(F)(F)c1ccc(CC(COCc2ccccc2)(COCc2ccccc2)Cc2ccc(C=O)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.41
PTPRC P08575 1/20 0.40
ALDH1A1 P00352 1/20 0.39
RECQL P46063 1/20 0.39
MMP8 P22894 1/20 0.39
KMT2A Q03164 1/20 0.38
AR P10275 4/20 0.37
PTPRB P23467 1/20 0.37
NR1H4 Q96RI1 1/20 0.36
ACSS2 Q9NR19 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7884519 0.82 PTPN1 (0.46) PTPN1PTPRCALDH1A1RECQLMMP8
SCHEMBL7879135 0.80 PTPN1 (0.43) PTPN1PTPRCALDH1A1RECQLMMP8
SCHEMBL1124743 0.80 TSHR (0.44) ALDH1A1KMT2ANR1H4ACSS2SMN1; SMN2
SCHEMBL7888188 0.79 PTPN1 (0.40) PTPN1PTPRCALDH1A1RECQLMMP8
SCHEMBL6951579 0.73 ALDH1A1 (0.41) ALDH1A1RECQLARPTPRBNR1H4
SCHEMBL20326484 0.73 LMNA (0.56) PTPN1PTPRCALDH1A1PTPRBNR1H4
SCHEMBL6950120 0.73 PTPRB (0.34) ALDH1A1PTPRBTSHR
SCHEMBL28943134 0.72 LMNA (0.48) ALDH1A1RECQLMMP8KMT2ATAAR1
SCHEMBL8743568 0.72 ALDH1A1 (0.47) ALDH1A1RECQLMMP8KMT2ATAAR1
SCHEMBL6946520 0.72 PTPN1 (0.69) PTPN1PTPRCPTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115729-B1 PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PTP-1B MERCK FROSST CANADA INC (CA) 2003-02-19 EP disclosed
US-6174874-B1 ANTIDIABETIC,-CARCINOGENIC AGENTS; IMPROVING GLUCOSE TOLERANCE/INSULIN-SENSITIVITY; PREVENTING/TREATING OBESITY AND NEURODEGENERATIVE DISEASES; E.G. 1,3-BIS-((PHOSPHONODI-FLUOROMETHYL)PHENYL)-2-DICARBOXYPROPANE MERCK FROSST CANADA & CO. (CA) 2001-01-16 US disclosed